Atopic dermatitis (AD) has a drastic impact on human health owing to complex skin, gut microbiota, and immune responses. Some lactic acid bacteria (LAB) are effective in ameliorating AD; however, the alleviative effects of dairy products derived from these LAB remain unclear. In this study, the efficacies of Lactococcus chungangensis CAU 28 (CAU 28) cream cheese and L. chungangensis CAU 28 dry cells were evaluated for treating AD in an AD mouse model. Overall, CAU 28 cream cheese administration was more effective against AD than L. chungangensis CAU 28 dry cells. Faeces from CAU 28 cream cheese-administered mice had increased short chain fatty acid, butyrate, acetate, and lactic acid levels, as well as butyrate-producing bacteria, including Akkermansia, Bacteroides, Lactobacillus, and Ruminococcus. Furthermore, oral CAU 28 cream cheese administration resulted in regulatory T cell (Treg)-mediated suppression of T helper type 2 (Th2) immune responses in serum and mRNA expression levels in the ileum. Oral CAU 28 cream cheese further reduced IgE levels, in addition to eosinophil and mast cell numbers. Therefore, CAU 28 cream cheese administration induced a coordinated immune response involving short-chain fatty acids and gut microbiota, indicating its potential for use as a supplement for AD mitigation.
Recently, interest in fermented foods, particularly cheese, kefir, yogurt, and kimchi has risen because of their potential for health-promotion in a manner indirectly attributable to the food materials themselves1. Intake of fermented foods has the potential to increase gut microbes and daily consumption of fermented food products can temporarily introduce transient microbes into the indigenous gut microbiota2,3. Interestingly, the consumption of fermented dairy products incorporating beneficial bacteria modifies the gut microbiota toward an increase in production of butyrate (a short-chain fatty acid [SCFA] metabolite produced by gut microbiota) relative to that induced by chemically acidified milk4.
Cheese is one of the most variable fermented milk-based food products and comprises biochemically and biologically dynamic matrices influenced by microbial activity and composition5. Moreover, cheese is useful as a delivery system to introduce probiotics into the gastrointestinal tract and can reduce the likelihood of a highly acidic gut environment, thereby promoting probiotic survival6. Among cheeses, cream cheese is a soft fresh cheese with a slightly buttery flavour, prepared using pasteurized milk and lactic acid bacteria (LAB) as the starter culture7.
LAB are a group of gram-positive organisms comprising species of Lactococcus, Lactobacillus, Leuconostoc, Pediococcus, and Streptococcus8. Some LAB strains, such as Lactobacillus spp., Lactococcus lactis, and Bifidobacterium spp. are important in maintaining gut homeostasis and provide health benefits through balancing T helper type 1 (Th1) and T helper type 2 (Th2) immune responses9,10. Among LAB, Lactococcus spp. are used as starter cultures for the production of cheese and fermented milk-based products; however, their probiotic function has frequently been underestimated because of an assumption that they cannot survive in the gastrointestinal tract11.
The specific strain, Lactococcus chungangensis CAU 28, isolated from non-dairy environments is the sixth member of genus Lactococcus12. This strain was previously examined by transcriptomic analysis for the presence of functional genes, including those encoding cystathionine β-lyase (MetC), O-acetylserine sulfhydrylase (CysK), alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), and activities of other enzymes, such as amylase, proteinase, and lipase13,14,15,16. L. chungangensis CAU 28 has been shown to be beneficial for the treatment of AD17; however, that study focused solely on the application of L. chungangensis CAU 28 in Nc/Nga mice and did not reveal any underlying mechanism of action.
Atopic dermatitis (AD) is a chronic inflammatory skin disease caused by a variety of genetic, environmental, and immunological factors, alongside exposure to microorganisms or allergens18. Abnormal Th2-type immune responses associated with skin damage or exposure to microbial stimuli are proposed as major mechanisms underlying AD19. Traditionally, topical corticosteroids, tacrolimus, and antihistamines have been used as basic treatments for AD to reduce inflammation; however, these approaches can trigger side effects and simply alleviate the symptoms rather than the underlying aetiology20,21. The applications of gut microbiota in disease treatment has garnered an increasing level of interest in recent years22. Numerous studies have reported potential beneficial effects of probiotics, including the specific strain, Lactobacillus rhamnosus GG. However, the applications of isolated bacterial strains with probiotic effects are limited, while the use of probiotic mixtures may have negative effects or may yield data that is difficult to interpret23,24,25.
It is important to identify treatments that target AD without triggering systemic side effects. To address this, recent studies on probiotics and gut microbiota, which have important nutrient and immune functions, have focused on the prevention or treatment of AD26. In the present study, a comprehensive investigation was conducted to explore the potential alleviative effects of cream cheese-derived L. chungangensis CAU 28 with L. chungangensis CAU 28 dry cells and bepotastine besilate. Furthermore, the effects of these supplements were evaluated based on analyses of immune response modulation and alterations in the gut microbiota in an AD mouse model.
Effects of L. chungangensis CAU 28 cream cheese on mouse gut microbiota profiles
Five-week-old female BALB/c mice (n = 50) were randomly assigned to five groups (n = 10/group) as follows: (1) negative control group, which included mice that were not subjected to ovalbumin (OVA) sensitization and orally administered with phosphate-buffered saline (PBS); (2) positive control group, sensitized with OVA and orally administered with PBS; (3) bepotastine besilate (BB) group, sensitized with OVA and orally administered with BB (an antihistamine); (4) L. chungangensis CAU 28 (CAU 28) group, sensitized with OVA and orally administered with freeze-dried L. chungangensis CAU 28; (5) L. chungangensis CAU 28 (CAU 28) cream cheese group, sensitized with OVA and orally administered with cream cheese prepared using L. chungangensis CAU 28.
To identify changes in microbial diversity, bacterial DNA was isolated from 16-week-old faecal samples and 16 S rDNA was PCR-amplified and subjected to Illumina-based high-throughput sequencing. In total, 5,035,756 bacterial sequence reads were generated, with an average of 100,715 sequence reads and an average read length of 598 bp (±8.8 bp) per sample. The diversity, evenness, and richness of the bacterial community was statistically determined from sequencing data based on the observed number of species, Chao1, ACE, Shannon, Simpson, and InvSimpson indices. The observed number of species, Chao1, and ACE indices indicated greater species richness in the CAU 28 cream cheese group than in the other groups (p < 0.05; Fig. 1a). Moreover, the CAU 28-derived cream cheese group exhibited greater diversity and evenness in gut microbiota compared with the positive control group, as indicated by Shannon, Simpson, and InvSimpson indices (p < 0.05; Fig. 1a; Table S1).
Furthermore, to assess the differences in microbiota profiles, constrained correspondence analysis (CCA), detrended correspondence analysis (DCA), and redundancy analysis (RDA) were performed. The results of CCA and DCA indicated that the relationship between the difference of microbial community, and the CAU 28 cream cheese group showed significant correlations with negative group (p < 0.05). According to the results of these correlation analysis, RDA result also showed that negative control, CAU 28 cream cheese, and BB were clustered into significant distinct from others (p < 0.05).
Overall, the results demonstrated a significant difference between the CAU 28 cream cheese group and the positive control group (p < 0.05; Fig. 1b). Together, the present results indicate that the gut microbiota of the CAU 28 cream cheese group was significantly different from that of the positive control group.
Fourteen bacterial phyla were identified in the mice, of which the three most predominant were Firmicutes, Bacteroidetes, and Verrucomicrobia (Fig. S1). Sixty bacterial families were identified in the experimental groups, among which Veillonellaceae, Prevotellaceae, Verrucomicrobiales, Rikenellaceae, Bacteroidales, Bacteroidaceae, and Lactobacillaceae were most prominent (Fig. S2). These phyla and families included 129 genera, seven of which exhibited significant differences in abundance among the experimental groups (Fig. 2 and Table S2). Within phylum Firmicutes, the predominance of family Faecalibacterium was significantly lower in the negative control group, CAU 28, and CAU 28 cream cheese groups than in the positive control group (p < 0.0001). Conversely, Ruminococcus displayed a significantly greater predominance in the negative control (p < 0.01), CAU 28 (p < 0.05), and CAU 28 cream cheese groups (p < 0.05) than in the positive control group. Moreover, in this phylum, family Lactobacillus was more abundant in the negative control group (p < 0.001), CAU 28 (p < 0.0001), CAU 28 cream cheese group (p < 0.0001), and BB group (p < 0.05) than in the positive control group. In phylum Bacteroidetes, the predominance of family Prevotella was lower in the negative control (p < 0.0001) and treatment groups (p < 0.0001) than in the positive control group. In contrast, Alistipes was more abundant in the negative control (p < 0.05), CAU 28 cream cheese (p < 0.05), and BB groups (p < 0.0001) than in the positive control group. Moreover, Bacteroides were present at significantly higher levels in the CAU 28 cream cheese-treated group (p < 0.05) than in the positive control group. Akkermansia (phylum Verrucomicrobia) was more abundant in the negative control (p < 0.0001) and CAU 28 cream cheese groups (p < 0.05) than in the positive control group. These present results indicate that the gut microbiota and the abundance of their genera differed between the CAU 28 cream cheese and positive control groups.
Treatment of AD mice with L. chungangensis CAU 28 cream cheese led to upregulation of SCFA levels
To compare gut microbiota metabolite production in the experimental groups, faecal samples were examined for acetate, butyrate, and formate using high-performance liquid chromatography (HPLC; Fig. 3). SCFA, butyrate and acetate, and lactic acid levels were lower in the positive than in the negative control group. Faecal samples from the CAU 28 and CAU 28 cream cheese groups contained significantly higher levels of acetate and lactic acid, and those from the CAU 28 cream cheese group had significantly higher levels of butyrate than the positive control group.
Effect of L. chungangensis CAU 28 cream cheese on cytokine levels and mRNA expression levels
To examine the effects of CAU 28 and CAU 28 cream cheese on cytokine production, serum cytokine concentrations were examined (Fig. 4). The serum concentration of cytokines produced by regulatory T cells (Tregs), such as IL-10 and IL-1β, increased in the positive control group compared with the CAU 28, CAU 28 cream cheese, and BB groups. Serum concentrations of IL-4 and IL-5, which are important Th2 cytokines, were significantly lower in the CAU 28, and CAU 28 cream cheese groups than in the positive control group; however, levels of the Th1 cytokines, IL-12, IFN-γ, and TNF-α, were lower in the positive control group than in the CAU 28 and CAU 28 cream cheese groups. Furthermore, to evaluate the effect of CAU 28 and CAU 28 cream cheese on the Th1/Th2 balance in ileum, Th1, Th2, and Treg type response-related inflammatory mRNA expression was examined (Fig. 5). Most mRNA expression levels of Th2 cytokines (IL-4 and IL-5) and Treg cytokines (IL-10 and IL-1β) were significantly downregulated in the CAU 28, and CAU 28 cream cheese groups than in the positive control group, and the levels of the Th1 cytokines (IL-12, TNF-α and IFN-γ) increased following stimulation with CAU 28 cream cheese. These results indicate that cream cheese prepared using L. chungangensis CAU 28 enhances the Treg-mediated suppression of Th2 immune responses.
Evaluation of the correlation between bacteria types and the expression of immune co-stimulatory molecules by flow cytometric analysis
To evaluate and compare the expression levels of the immune co-stimulatory molecules, CD80, CD86, CD273, and CD274, splenocytes were isolated from the treatment groups for flow cytometric analysis. Compared with the control group, CD 86 expression (MFI; mean florescence intensity) was significantly lower in the CAU 28 cream cheese-treated group (31.52% ± 1.33%, p < 0.05) (Fig. 6). Additionally, compared with the positive control group, CD 274 expression was significantly higher in the CAU 28 (44.22% ± 1.52%, p < 0.005), CAU 28 cream cheese (43.81% ± 3.23%, p < 0.05), and BB (46.21% ± 4.20%, p < 0.001) groups (Fig. 5). No significant changes in CD80 and CD273 expression levels were observed in any of the groups.
At the family level, bacterial taxa formed a complex network relative to the expression of co-stimulatory molecules CD86 and CD274 (Fig. 7). There was a positive correlation between CD 274 and the Bacteroidales, Prevotellaceae, and Oscillospiraceae families (p < 0.05) in the CAU 28 group; while there was negative correlation between Desulfovibrionaceae and CD 86 in this group (p < 0.05). CD86 expression levels were significantly correlated with the presence of several bacterial families, including Verrucomicrobiales, while those of CD274 correlated significantly with families Veillonellaceae, Rikenellaceae, Oscillospiraceae, and Deferribacteraceae in the CAU 28 cream cheese group (p < 0.05).
Effects of L. chungangensis CAU 28 cream cheese on blood and serum IgE levels
Serum IgE levels were elevated in the positive control group and significantly decreased in the CAU 28, CAU 28 cream cheese, and BB groups (Fig. 8a). Moreover, eosinophil, neutrophil, lymphocyte, and monocyte percentages in whole blood were greater in the positive control group than in the negative control group, similar to the trend observed for eosinophils (Fig. 8b–f). Eosinophil count, and eosinophil, neutrophil, and monocyte percentages were significantly lower in the CAU 28 and CAU 28 cream cheese groups than in the positive control group. Moreover, lymphocytes were significantly less abundant in the CAU 28 cream cheese group than in the CAU 28 and BB groups.
Effect of L. chungangensis CAU 28 cream cheese on skin and gut inflammation
To investigate the therapeutic effects of L. chungangensis CAU 28 cream cheese, mice were sensitized with ovalbumin (OVA) to induce an inflammatory response. OVA-sensitized mice treated with CAU 28, CAU 28 cream cheese, and BB were evaluated via dermatitis scoring and histological analysis. Dermatitis scores were significantly lower in OVA-sensitized mice treated with CAU 28, and CAU 28 cream cheese than in the positive control group (Fig. 9a). This result indicates that CAU 28, and CAU 28 cream cheese had a pronounced effect on the recovery of skin lesions in these mice.
Local mast cell infiltration into dorsal skin and ileal lesions was examined and quantified via Toluidine Blue staining. This analysis revealed that mast cell accumulation at both lesion sites was suppressed in OVA-sensitized mice treated with CAU 28 and CAU 28 cream cheese (Fig. 9b,c). In addition, the number of eosinophils was significantly lower in OVA-sensitized mice treated with CAU 28, CAU 28 cream cheese, and BB than in the positive control group. Congo Red staining revealed reduced eosinophil infiltration in the dorsal skin lesions of OVA-sensitized mice treated with of CAU 28, CAU 28 cream cheese, and BB (Fig. 9d). Together, these results indicate that CAU 28 and CAU 28 cream cheese can suppress mast cell and eosinophil infiltration into dorsal skin and ileal lesions in OVA-sensitized mice.
Numerous studies have investigated the potential therapeutic effects of probiotics in AD. These studies have primarily used beneficial Lactobacillus spp. and Bifidobacterium spp. strains27. The most frequently used strain in these studies was L. rhamnosus GG, and a number of studies have suggested that this strain is beneficial in preventing the onset AD, either alone or as part of a probiotic mixture28,29; however, several other studies reported that the L. rhamnosus GG strain, either alone or as part of mixed cultures, has limited effects24,25 or confers no significant benefit30 in the treatment of AD. Recently, it was reported that consumption of yogurt, which contains Lactobacillus spp., is inversely associated with AD and affects the gut microbiota; nevertheless the mechanisms underlying these phenomena remain poorly understood31. Thus, the utility of probiotics in treating AD remains unclear.
SCFAs have emerged as important biological indicators for both maintenance of health and disease pathogenesis32. Gut microbiota are known to synthesize SCFAs33, which are potential mediators of the activity and composition of the gut microbiota34; hence, these primary metabolic end products of gut microbiota are important for gut homeostasis and health. Furthermore, SCFAs (namely butyrate, acetate, and propionate) exert physiological effects4,35. Among SCFAs, butyrate is important in innate immunity, maintenance of gut health, exerts anti-inflammatory effects, and stimulates Treg differentiation36. In the present study, high SCFA (butyrate and acetate) and lactic acid levels were associated with changes in the gut microbiota in the CAU 28 and CAU 28 cream cheese groups. These groups contained an abundance of the genera Lactobacillus (family Lactobacillaceae), Bacteroides (family Bacteroidaceae) (except for the CAU 28 group), Ruminococcus (family Clostridiaceae), and Akkermansia (family Verrucomicrobiales) (except for the CAU 28 group), while members of genus Faecalibacterium (family Clostridiaceae) were less abundant. A low capacity for SCFA production (butyrate and propionate) is associated with abundance of specific gut bacteria, such as Faecalibacterium spp. in AD37, and an abundance of members of genera Lactobacillus, Bacteroides, Ruminococcus, and Akkermansia is associated with the maintenance of gut health via production of lactate and other SCFAs38,39. The results presented here demonstrate an abundance of butyrate-producing bacteria associated with an increase in metabolic activity. Moreover, these data suggest that the beneficial effects of L. chungangensis CAU 28 cream cheese result from interactions between the gut microbiota and SCFAs in AD.
In the present study, to elucidate the mechanisms underlying their role in AD treatment, the effects of L. chungangensis CAU 28 cream cheese and freeze-dried L. chungangensis CAU 28 on the immune response and gut microbiota were investigated in BALB/c mice. CD86 expression was associated with bacterial taxa at the family level (Verrucomicrobiales) and CD274 expression was associated with five bacterial families (Veillonellaceae, Rikenellaceae, Oscillospiraceae, and Deferribacteraceae) in the CAU 28 cream cheese group. In addition, CD86 and CD274 were significantly down- and upregulated, respectively, in the CAU 28 cream cheese group. CD86 is a co-stimulatory molecule for T-cell activation, which is expressed on antigen-presenting cells and is regulated in response to IL-1040, while CD274, which is associated with impaired immune regulatory function, is downregulated in response to IFN-γ41. Furthermore, mice treated with CAU 28 and CAU 28 cream cheese displayed significantly lower levels of Th2 (IL-4 and IL-5) and Treg (IL-10) cytokines, and higher levels of Th1 cytokines (IL-12, TNF-α, and IFN-γ) than the positive control group. Mice treated with bepotastine besilate displayed significant suppression of Th2 cytokines in the serum; however, these cytokines were upregulated in the intestine, in comparison with the positive control group. The effects of bepotastine besilate in AD are associated with the suppression of Th2 cytokines; however, no effects are exerted sometimes42. Suppression of IL-4, IL-5, and IL-10 was associated with low IgE titres and reduced eosinophil, lymphocyte, and monocyte counts. Activation of Th1 cells was associated with a higher neutrophil count43,44,45; therefore, the present results suggest that L. chungangensis CAU 28 cream cheese affects AD recovery through restoration of the Th2/Th1 balance.
The gut microbial community was analysed to investigate the association between immunomodulation and gut microbiota, revealing higher levels of bacteria of the genus Faecalibacterium and lower levels of the Ruminococcus, Lactobacillus, and Bacteroides genera in the positive control group compared with the CAU 28 cream cheese group. These strains are considered important gut microbiota in AD. High levels of Faecalibacterium prausnitzii are associated with exacerbated inflammation, reductions in SCFA levels, and altered Th2-type immune responses40. Bacteroides fragilis induces Tregs and IL-10, while L. plantarum and L. rhamnosus GG produces small-molecule immunomodulators, such as the anti-inflammatory cytokine, IL-1028,46. Genus Ruminococcus is associated with high IgE levels39. Interestingly, a high bacterial count of Akkermansia spp. (family Verrucomicrobiales) was observed in the CAU 28 cream cheese group and the negative control group. These strains are mucin-degrading and are reportedly associated with energy metabolism and homeostasis; however, their exact functions in the present context remains unclear47. Nevertheless, previous studies have reported that an abundance of Akkermansia spp. bacteria is associated with anti-inflammatory responses in diseases including type 1 and 2 diabetes mellitus48,49, inflammatory bowel disease50, and obesity51.
In the present study, L. chungangensis CAU 28 and CAU 28 cream cheese modulate gut microbiota, followed by metabolite production and modulation of the immune response for therapeutic effects in AD. These results are concurrent with previous results wherein pro- and prebiotic administration (foodstuffs) and faecal microbiota transplantation (FMT) are considered therapeutic, since these modulate the gut microbiota while simultaneously restoring physiological functions via production of metabolites owing to the stimulation as beneficial bacteria growth52,53. In the present study, concurrently, treatment with CAU 28 cream cheese yielded superior results compared with CAU 28 alone, probably because of the presence of additional compounds in L. chungangensis CAU 28 cream cheese. Previously, 14 SCFAs were detected in L. chungangensis CAU 28 cream cheese via gas chromatography analysis (data not shown). Of the SCFAs detected, oleic acid (omega-9) stabilizes the lipid lamellar sheet, thereby potentially reducing water loss from the skin54. In addition, linoleic acid (omega-6) plays a role in skin barrier permeability and can modulate immune responses associated with inflammatory dermatoses, psoriasis, and AD55. Furthermore, α-linoleic acid (omega-3) is an important regulator of transcription factors related to lipid metabolism, inflammation, immune regulation, and skin barrier homeostasis55,56. Therefore, L. chungangensis CAU 28 cream cheese is probably more effective in treating AD than purified L. chungangensis CAU 28 because it provides these SCFAs.
In conclusion, treatment of AD with L. chungangensis CAU 28 cream cheese yielded beneficial results, including the suppression of Th2 immune responses, a gut microbiota profile similar to that of the negative control group, and high SCFA levels (Fig. 10). Together, these results provide a deeper insight into the immune mechanisms, gut microbiota, and SCFA modulation in AD. Moreover, these data suggest that oral administration of the dairy product, L. chungangensis CAU 28 cream cheese has potential applications in preventing or treating AD. L. chungangensis CAU 28 cream cheese thus serves as an alternative treatment for AD, although complementary clinical trials are necessary.
Ethics and animals
Five-week-old female BALB/c mice (n = 50) were purchased from Central Lab Animal Incorporation (Korea) and allowed to acclimate for 1 week before the start of the experiments. Five mice were housed in a cage with ad libitum access to a nutritionally complete chow and water under a 12:12-h light/dark cycle. The temperature and humidity were maintained at 24 °C ± 2 °C and 55% ± 10%, respectively. Animal studies were performed in accordance with the Korean Food and Drug Administration guidelines. Samples were collected from mice under the animal ethical guidelines mandated by the protocol presented to and approved by the Chung-Ang University Institutional Animal Care and Use Committee of the Laboratory Animal Research Center (No. 2017–00044). Mice were randomly assigned to five groups (n = 10/group): (1) negative control (non-OVA sensitization + PBS), (2) positive control (OVA sensitization + PBS), (3) BB (OVA sensitization + BB), (4) L. chungangensis CAU 28 (OVA sensitization + L. chungangensis CAU 28), and (5) CAU 28 cream cheese group (OVA sensitization + cream cheese derived L. chungangensis CAU 28). To induce AD in mice via skin sensitization, the dorsal skin of each mouse was shaved using electric clippers and hair removal cream. OVA grade V (Sigma-Aldrich, USA) (50 mg/mL) with alum (Sigma-Aldrich) in PBS was intraperitoneally injected on days 7, 21, 35, and 49, and mice were epicutaneously sensitized for 8 weeks, as previously described57,58 (Fig. S3). Freeze-dried L. chungangensis CAU 28 (1 × 1010 colony forming units/mouse) and cream cheese prepared with L. chungangensis CAU 28 (1.4 g/kg/mouse), were dissolved in 200 μl of sterilized water, and administered via an oral gavage. The negative control group was treated with an equal volume of PBS for 8 weeks. BB, the positive treatment control, was administered orally once a day for 8 weeks (0.5 mg/kg). Thereafter, mice were euthanised, and the dorsal skin, ileum, spleen, and blood were harvested for further analyses.
DNA sample preparation, high-throughput sequencing, and microbiome analysis
Faecal samples, collected after 16 weeks of treatment, from individual mice in sterile 2 mL microcentrifuge tubes, were immediately transported on ice, and stored at −80 °C. DNA was extracted using a FastDNA SPIN kit for bacterial DNA (MP Biomedicals, USA) in accordance with the manufacturer’s instructions. PCR amplification of the 16 S rRNA gene V3–V4 region was performed using MiSeq-based high throughput sequencing (Illumina, USA). Samples that passed quality control were used to construct a library. After sequencing, adapter sequences were removed from the resulting data using the programs Scythe (v 0.994; https://github.com/vsbuffalo/scythe) and Sickle (https://github.com/vsbuffalo/scythe). Sequences were trimmed to eliminate short reads (<36 bp), extra-long tails, chimeric reads, and noise sequences, using CD-HIT-OTU (http://weizhong-lab.ucsd.edu/cd-hit-otu)59. The minimum quality score and length of merged reads were >20 and 300 bp, respectively. Remaining representative sequences were clustered and operational taxonomic units (OTUs) defined at a cutoff of 97% similarity, using CD-HIT-OTU. Microbiome analysis was conducted upon defining OTUs, using UCLUST and taxonomic assignment was achieved using QIIME (Quantitative Insight Into Microbial Ecology; v.1.9.1)60 by screening data in the 16 S rRNA sequence database of the Ribosomal Database Project (RDP; release 11.0, update 5) (http://rdp.cme.msu.edu/). α-diversity was calculated from the following indices: observed number of species, Chao1, and ACE (richness estimators); and Shannon, Simpson, and InvSimpson (estimators of sample diversity). The ordinate function supported constrained correspondence analysis (CCA), detrended correspondence analysis (DCA), and redundancy analysis (RDA). For CCA, DCA, and RDA, ordination was based on an evaluation of abundance values, but not ecological distance. The CCA and DCA were used to determine the correlation among groups, while RDA was used to determine that explained most of the variance in the groups. Moreover, correlation of bacterial taxa at the family level with data from flow cytometry analysis (CD 86 and CD 274) were determined using frequency tables for bacteria at various levels of taxonomic resolution analysed using a Spearman non-parametric rank correlation matrix.
Analysis of short-chain fatty acids in faecal samples
SCFA and lactic acid content in mouse faecal samples were analysed via HPLC (Ultimate 3000, Thermo Dionex, USA). Briefly, faecal samples (100 mg) were homogenized for 10 min in 0.005 M aqueous NaOH containing 5 μg/ml caproic acid (Sigma-Aldrich), and centrifuged at 12,000 × g for 20 min at 4 °C. Aliquots of supernatants were transferred to disposable glass centrifuge tubes (Corning, USA) and stored at −80 °C until required for HPLC analysis. SCFAs were separated using an Aminex 87 H column (300 × 10 mm; Bio-Rad, USA), using an isocratic 0.01 N H2SO4 mobile phase (Fluka, USA) at a flow rate of 0.5 ml/min and a temperature of 40 °C. Volatile organic acid (VOA) mixtures (including formic, acetic, propionic, isobutyric, and butyric acid) and lactic acid were detected at 210 nm, using an RI-detector (ERC, RefractoMax 520, Japan). Acids were identified via comparison with the corresponding standards: (VOA mixture, 10 mM; AccuStandard FAMQ-004, USA).
Blood and serum cytokine analysis
Blood was collected via puncturing of the retro-orbital sinus via the medial canthus of the eye. Whole blood was collected in spray-dried EDTA tubes (Green Cross Laboratories, Korea) to enumerate eosinophils and immediately mixed to prevent coagulation. Blood was then coagulated for 1 h at 4 °C and centrifuged for 1 h at 5,000 × g for IgE and cytokine (IL-4, IL-5, IL-10, IL-12, IL-1β, TNF-α, and IFN-γ) analyses. Serum was stored at −80 °C until analysis. Cytokine levels were measured using ELISA kits (R&D systems, USA) in accordance with the manufacturer’s instructions. Absorbance was measured at 450 nm, using a microplate reader.
Analysis of mRNA expression in ileal tissue recovered from formalin-fixed paraffin-embedded (FFPE) slides
Twenty-micrometre-thick unstained ileal tissue sections were obtained using a microtome (Leica, Germany) for RNA extraction and deparaffinized using Deparaffinization Solution (Qiagen, USA) at 56 °C for 3 min, followed by cooling at room temperature, and completely digested by proteinase K at 56 °C for 15 min and at 80 °C for 15 min. Thereafter, DNase I was used to eliminate DNA. RNA from FFPE samples were extracted using RNeasy FFPE kit (Qiagen) in accordance with the manufacturer’s protocol (RNeasy FFPE handbook). The quantity of RNA was measured using NanoQuant spectrophotometer (Infinite 200; Tecan, Switzerland). Thereafter, first-strand cDNA synthesis was performed using 1 μg of total RNA with oligo dT primer (50 μM), using the PrimeScript 1st strand cDNA synthesis kit (Takara, Japan). Target mRNA (IL-4, IL-5, IL-10, IL-12, IL-1β, TNF-α, and IFN-γ) expression levels were analysed using ABI Fast 7500 real-time system instruments (Applied Biosystems, USA) and were normalised relative to the expression levels of housekeeping gene (36B4; ribosomal protein RPLP0), using. the comparative Ct method and the 2−ΔΔCt formula.
Flow cytometry analysis
Harvested spleens were homogenised for 3 min at room temperature in 50-mm tissue culture Petri dishes (Nunclon, Denmark) in ammonium chloride potassium (ACK) lysing buffer (Gibco, USA) to lyse erythrocytes. Samples were filtered using a cell strainer (SPL, Korea) and washed in 2% RPMI (Hyclone, USA). After centrifugation at 2,000 × g for 10 min at 4 °C, supernatants were discarded, and pellets resuspended in 2% RPMI. Splenocytes were enumerated, and their viability was assessed using Trypan Blue. Cells were diluted to 2.0 × 106 cells per tube and incubated on ice with phycoerythrin (PE)-labelled anti-mouse antibodies: CD80, CD86, CD273, or CD274 (BD Pharmingen, USA) for 20 min. Cell surface expression of different molecules was assessed by recording at least 10,000 events, using a flow cytometer (FACSCalibur; Becton Dickinson, USA). Mean fluorescence intensity (MFI) data were analysed using a FACSCalibur instrument and Cell Quest software (version 6.0).
Evaluation of dermatitis scores
Dermatitis severity in the dorsal skin of OVA-sensitized AD mice was evaluated based on the occurrence of erythema, dryness, and scratching behaviour within 15 min after 1-, 8-, and 16-week sensitization. Severity scores were 0 (none), 1 (mild), 2 (moderate), or 3 (severe). Final scores were calculated as the sum of individual scores.
FFBE dorsal skin and ileal tissue of the euthanised mice were used for histological analysis. Tissues were fixed in 10% formalin in PBS and embedded in paraffin. Tissue sections were cut at 4–5-μm thickness and stained with haematoxylin and eosin for histological general analysis, and with Toluidine Blue and Congo Red for mast cell and eosinophil evaluation, respectively. All fields of Toluidine Blue-stained ileum sections were observed to enumerate mast cells at 400× magnification. Five random fields of Toluidine Blue-stained dorsal skin sections were chosen for mast cell quantification and twenty random fields of Congo Red-stained dorsal skin sections were chosen for eosinophil quantification at 400× magnification.
Statistical analysis was performed using GraphPad Prism (v.7.0) and data are presented as mean ± standard error of the mean (SEM) values. To evaluate relative differences, statistically significant differences between groups were determined using the non-parametric Kruskal-Wallis test for microbial phyla and genera and one-way analysis of variance for multiple-group comparisons in cytokine, flow cytometry, blood, histologic, and SCFA analyses. P-values less than 0.05 were considered significant.
Samples were collected from mice in accordance with the animal ethical guidelines mandated by the protocol presented to and approved by the Chung-Ang University Institutional Animal Care and Use Committee of the Laboratory Animal Research Center (No. 2017–00044).
The nucleotide sequences are deposited in GenBank under accession number SRP149062.
Marco, M. L. et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotech 44, 94–102 (2017).
Lang, J. M., Eisen, J. A. & Zivkovic, A. M. The microbes we eat: abundance and taxonomy of microbes consumed in a day’s worth of meals for three diet types. Peerj 2, e659 (2014).
Ple, C., Breton, J., Daniel, C. & Foligne, B. Maintaining gut ecosystems for health: Are transitory food bugs stowaways or part of the crew? Int J Food Microbiol 213, 139–143 (2015).
Rios-Covian, D. et al. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol 7, 185 (2016).
De Filippis, F., Genovese, A., Ferranti, P., Gilbert, J. A. & Ercolini, D. Metatranscriptomics reveals temperature-driven functional changes in microbiome impacting cheese maturation rate. Sci Rep 6, 21871 (2016).
da Cruz, A. G., Buriti, F. C. A., de Souza, C. H. B., Faria, J. A. F. & Saad, S. M. I. Probiotic cheese: health benefits, technological and stability aspects. Trends Food Sci Tech 20, 344–354 (2009).
Phadungath, C. Cream cheese products: A review. Songklanakarin J Sci Technol 27, 191–199 (2005).
Bermudez-Humaran, L. G. et al. Engineering lactococci and lactobacilli for human health. Curr Opin Microbiol 16, 278–283 (2013).
Mileti, E., Matteoli, G., Iliev, I. D. & Rescigno, M. Comparison of the Immunomodulatory Properties of Three Probiotic Strains of Lactobacilli Using Complex Culture Systems: Prediction for In Vivo Efficacy. Plos One 4, e7056 (2009).
Gareau, M. G., Sherman, P. M. & Walker, W. A. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastro Hepat 7, 503–514 (2010).
Yoshida, A. et al. Oral administration of live Lactococcus lactis C59 suppresses IgE antibody production in ovalbumin-sensitized mice via the regulation of interleukin-4 production. FEMS Immunol Med Mic 61, 315–322 (2011).
Cho, S. L. et al. Lactococcus chungangensis sp nov., a lactic acid bacterium isolated from activated sludge foam. Int J Syst Evol Micr 58, 1844–1849 (2008).
Konkit, M., Kim, J. H., Bora, N. & Kim, W. Transcriptomic analysis of Lactococcus chungangensis sp. nov. and its potential in cheese making. J Dairy Sci 97, 7363–7372 (2014).
Konkit, M., Choi, W. J. & Kim, W. Aldehyde dehydrogenase activity in Lactococcus chungangensis: Application in cream cheese to reduce aldehyde in alcohol metabolism. J Dairy Sci 99, 1755–1761 (2016).
Konkit, M., Choi, W. J. & Kim, W. Alcohol dehydrogenase activity in Lactococcus chungangensis: Application in cream cheese to moderate alcohol uptake. J Dairy Sci 98, 5974–5982 (2015).
Konkit, M. & Kim, W. Activities of amylase, proteinase, and lipase enzymes from Lactococcus chungangensis and its application in dairy products. J Dairy Sci 99, 4999–5007 (2016).
Choi, W. J., Konkit, M., Kim, Y., Kim, M. K. & Kim, W. Oral administration of Lactococcus chungangensis inhibits 2,4-dinitrochlorobenzene-induced atopic-like dermatitis in NC/Nga mice. J Dairy Sci 99, 6889–6901 (2016).
Williams, H. & Flohr, C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immun 118, 209–213 (2006).
Brandt, E. B. & Sivaprasad, U. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2, 110 (2011).
Martins, J. C. et al. Topical tacrolimus for atopic dermatitis. Cochrane Db Syst Rev 7 (2015).
Werfel, T. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy. J Dtsch Dermatol Ges 7, 739–743 (2009).
Choi, H. H. & Cho, Y. S. Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc 49, 257–265 (2016).
Van Der Aa, L. B., Heymans, H. S., Van Aalderen, W. & Sprikkelman, A. B. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediat Allerg Imm 21, 2p2 (2010).
Allen, S. J. et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child 99, 1014–1019 (2014).
Niccoli, A. A. et al. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J Clin Gastroenterol 48, S34–S36 (2014).
Noverr, M. C. & Huffnagle, G. B. The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy 35, 1511–1520 (2005).
Jeong, J. H., Lee, C. Y. & Chung, D. K. Probiotic lactic acid bacteria and skin health. Crc Cr Rev Food Sci 56, 2331–2337 (2016).
Nermes, M., Kantele, J., Atosuo, T., Salminen, S. & Isolauri, E. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin Exp Allergy 41, 370–377 (2011).
Frei, R., Akdis, M. & O’Mahony, L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroen 31, 153–158 (2015).
Gore, C. et al. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy 42, 112–122 (2012).
Shoda, T. et al. Yogurt consumption in infancy is inversely associated with atopic dermatitis and food sensitization at 5 years of age: A hospital-based birth cohort study. J Dermatol Sci 86, 90–96 (2017).
Tan, J. et al. The role of short-chain fatty acids in health and disease. Adv Immunol 121, 91–119 (2014).
Chassard, C. et al. Assessment of metabolic diversity within the intestinal microbiota from healthy humans using combined molecular and cultural approaches. FEMS Microbiol Ecol 66, 496–504 (2008).
Janssen, A. F. & Kersten, S. Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol-London 595, 477–487 (2017).
Riviere, A., Selak, M., Lantin, D., Leroy, F. & De Vuyst, L. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol 7, 979 (2016).
Kim, H. K. et al. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Beneficial Microbes 6, 783–790 (2015).
Song, H., Yoo, Y., Hwang, J., Na, Y. C. & Kim, H. S. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immun 137, 852–860 (2016).
Kumari, M. & Kozyrskyj, A. L. Gut microbial metabolism defines host metabolism: an emerging perspective in obesity and allergic inflammation. Obes Rev 18, 18–31 (2017).
West, C. E. et al. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy 45, 1419–1429 (2015).
Zhu, X. Y. et al. Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages. Alcohol 32, 91–100 (2004).
Lee, S. J. et al. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett 580, 755–762 (2006).
Tamura, T., Amano, T., Ohmori, K. & Manabe, H. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 524, 149–154 (2005).
Owaga, E. E., Elbakkoush, A., KS, M. S. & Lupia, R. Antiallergic effects of probiotic lactobacilli–cellular and molecular mechanisms. J Microbiol Res 4, 92–97 (2014).
Otsuka, A. et al. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev 278, 246–262 (2017).
Endo, Y. et al. Eomesodermin Controls Interleukin-5 Production in Memory T Helper 2 Cells through Inhibition of Activity of the Transcription Factor GATA3. Immunity 35, 733–745 (2011).
Kosiewicz, M. M., Dryden, G. W., Chhabra, A. & Alard, P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett 588, 4195–4206 (2014).
Huang, H. Q., Krishnan, H. B., Pham, Q., Yu, L. L. & Wang, T. T. Y. Soy and gut microbiota: interaction and implication for human health. J Agr Food Chem 64, 8695–8709 (2016).
Hansen, C. H. F. et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55, 2285–2294 (2012).
Ellekilde, M. et al. Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters. Res Vet Sci 96, 241–250 (2014).
Png, C. W. et al. Mucolytic bacteria with increased prevalence in ibd mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105, 2420–2428 (2010).
Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. P Natl Acad Sci-Biol 110, 9066–9071 (2013).
Baumann, L. Weisberg E. Olive oil in botanical cosmeceuticals. Olives and Olive Oil in Health and Disease Prevention (2010).
McCusker, M. M. & Grant-Kels, J. M. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin Dermatol 28, 440–451 (2010).
Eriksen, B. B. & Kare, D. L. Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis. J Dermatol Treat 17, 82–85 (2006).
Macia, L. et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 245, 164–176 (2012).
Hudson, L. E., Anderson, S. E., Corbett, A. H. & Lamb, T. J. Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies. Clin Microbiol Rev 30, 191–231 (2017).
Lee, J., Bang, J. & Woo, H. J. Immunomodulatory and anti-allergic effects of orally administered Lactobacillus species in ovalbumin-sensitized mice. J Microbiol Biotechn 23, 724–730 (2013).
Nonaka, Y. et al. Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production. Int Arch Allergy Imm 145, 249–257 (2008).
Li, W. Z., Fu, L. M., Niu, B. F., Wu, S. T. & Wooley, J. Ultrafast clustering algorithms for metagenomic sequence analysis. Brief Bioinform 13, 656–668 (2012).
Kuczynski, J. et al. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Bioinformatics 1E. 5.1-1E. 5.20 (2012).
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1A2B4008481).
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kim, JH., Kim, K. & Kim, W. Cream Cheese-Derived Lactococcus chungangensis CAU 28 Modulates the Gut Microbiota and Alleviates Atopic Dermatitis in BALB/c Mice. Sci Rep 9, 446 (2019). https://doi.org/10.1038/s41598-018-36864-5
Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy
Experimental & Molecular Medicine (2021)